NovaBay Pharmaceuticals Inc (NBY)
0.78
+0.03
(+4.00%)
USD |
NYAM |
Nov 04, 16:00
0.78
0.00 (0.00%)
After-Hours: 20:00
NovaBay Pharmaceuticals Asset Impairment Charge (Quarterly)
Asset Impairment Charge (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Asset Impairment Charge (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | -- |
| September 30, 2019 | -- |
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| June 30, 2018 | -- |
| March 31, 2018 | -- |
| December 31, 2017 | -- |
| September 30, 2017 | -- |
| Date | Value |
|---|---|
| June 30, 2017 | -- |
| March 31, 2017 | -- |
| December 31, 2016 | -- |
| September 30, 2016 | -- |
| June 30, 2016 | -- |
| March 31, 2016 | -- |
| December 31, 2015 | -- |
| September 30, 2015 | -- |
| June 30, 2015 | -- |
| March 31, 2015 | -- |
Asset Impairment Charge Definition
Asset Impairment Charge is a part of the consolidated statement of cash flows, specifically cash flows from operations. Asset impairment charges occur when the market value of a company's asset decreases below its book value. This process is called a writedown.